Nuvectis Pharma, Inc.
NASDAQ:NVCT · NASDAQ Capital Market
+$0.39 today
Vol 0.32M · Avg 0.08M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+73.62%
Period High
$13.82
Period Low
$5.65
Latest
$13.82
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cybin Inc.
CYBN
$413.02M
Armata Pharmaceuticals, Inc.
AMEX:ARMP
$258.63M
Tonix Pharmaceuticals Holding Corp.
NASDAQ:TNXP
$190.57M
Compugen Ltd.
NASDAQ:CGEN
$189.11M
Innate Pharma S.A.
NASDAQ:IPHA
$169.96M
Molecular Partners AG
NASDAQ:MOLN
$147.98M
Milestone Pharmaceuticals Inc.
NASDAQ:MIST
$112.08M
Cardiff Oncology, Inc.
NASDAQ:CRDF
$82.73M
Cassava Sciences, Inc.
SAVA
$63.77M
Rani Therapeutics Holdings, Inc.
NASDAQ:RANI
$50.36M
What is the latest NVCT filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does NVCT have?
Intrinsic Alpha currently shows 20 recent filings for NVCT.
Explore More
Continue the stock analysis
Jump to another research area for this company.